Table 2.
Overview of presentation of CSE episodes included in this study.
| Total episodes (n = 144) | PHB protocol (n = 72) | PHY protocol (n = 72) | p | |
|---|---|---|---|---|
| AXIS I: SEMIOLOGY | ||||
| Focal onset evolving into bilateral SE | 28 (19.4%) | 13 (18.1%) | 15 (20.8%) | 0.83 |
| Generalized | 93 (64.6%) | 46 (63.9%) | 47 (65.3%) | >0.99 |
| Unknown focal or generalized | 23 (16.0%) | 13 (18.1%) | 10 (13.9%) | 0.65 |
| TYPE Of CSE | ||||
| Continuous | 73 (50.7%) | 40 (55.6%) | 38 (52.8%) | 0.87 |
| Intermittent | 71 (49.3%) | 32 (44.4%) | 34 (47.2%) | |
| AXIS II: ETIOLOGY | ||||
| Acute | 86 (59.7%) | 45 (62.5% | 41 (56.9%) | 0.93 |
| Electroclinical | 20 (13.9%) | 10 (13.9%) | 10 (13.9%) | >0.99 |
| Remote | 24 (16.7%) | 13 (18.1%) | 11 (15.3%) | 0.82 |
| Unknown | 14 (9.7%) | 4 (5.6%) | 10 (13.9%) | 0.16 |
| Febrile status epilepticus | 27 (18.8%) | 14 (19.4%) | 13 (18.1%) | >0.99 |
| AXIS IV: AGE | ||||
| Age at admission- median months (IQR) | 28.1 (15.5–66.0) | 25.7 (13.1–65.6) | 22.2 (14.8–46.3) | 0.48 |
| Infancy (1 month−1 year) | 25 (17.4%) | 9 (12.5%) | 16 (22.2%) | 0.19 |
| Childhood (>1 year−12 years) | 119 (82.6%) | 63 (87.5%) | 56 (77.8%) | |
SE, status epilepticus; CSE, convulsive status epilepticus.